Baxdela
Active substance: delafloxacin meglumine
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · DELAFLOXACIN MEGLUMINE 300 mg/10.5mL
United StatesActive
Marketing holder: Melinta Therapeutics, LLC
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- DELAFLOXACIN MEGLUMINE · 300 mg/10.5mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-a8b7-76ed-a932-ebb8c916eb87,01a12094-ddcd-79d3-9ba3-408c1abaa9b4;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 70842-102
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 70842-102 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 70842-102 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 70842-102 · Verified 2026-10-09 · open in source